Message from the President & CEO

July 2022

We will push forward to achieve the targets of our Long-Term Business Plan, VISION 2030.

This year marks the 25th anniversary of the founding of Mitsui Chemicals. I would like to express my heartfelt gratitude to our shareholders for your support, which has allowed us to reach this milestone.

In fiscal 2021, the impact of COVID-19 was mitigated with the spread of vaccines and other measures, and economic activity began to recover. However, uncertainty over the future has suddenly increased with the crisis in Ukraine and other developments.

Despite these circumstances, full-year operating income before special items came to a record high of 161.8 billion yen (up 76.7 billion yen from the previous year). This was a result of improvement in terms of trade arising from favorable market conditions overseas and price revisions, as well as higher sales volumes in each segment and improvement in equity in earnings.

Based on this situation in our business results, we set the year-end regular dividend at 60 yen, which is 10 yen higher than the previous fiscal year. In addition, we provide a memorial dividend of 5 yen to commemorate the 25th anniversary of our founding and to express our gratitude to our shareholders. Combined with the interim dividend of 55 yen, this brings the full-year dividend to 120 yen (20 yen higher than the previous fiscal year).

Our VISION 2030 Long-Term Business Plan has officially started this April and we are now working in earnest to implement the plan. Under the new business sector structure, the management targets to be achieved by fiscal 2030 include 250 billion yen in operating income before special items and a 40% reduction of greenhouse gases (compared to fiscal 2013). The journey will be anything but easy, but the entire Group will push forward to achieve the targets.

I once again thank our shareholders and hope that we can continue to count on your support going forward.

President & CEO
July 2022



Hashimoto joined Mitsui Petrochemical Industries, Ltd. (currently Mitsui Chemicals, Inc.) in 1987, and subsequently held positions spanning human resources, health care and other businesses, and business planning fields.

In 2014, he was appointed General Manager of the Corporate Planning Division, where he spearheaded the formulation of Mitsui Chemicals’ long-term business plan for 2025.
Then in 2017, Hashimoto assumed the role of Managing Executive Officer. While also serving as Business Sector President of the Health Care Business Sector and General Manager of the New Health Care Business Development Division, he drove the expansion of the Health Care business, one of Mitsui Chemicals’ three target domains.
Hashimoto has been serving as President and CEO of Mitsui Chemicals since April 1, 2020.